Pediatric Plasmablastic Lymphoma in the Setting of CD70 Deficiency

Area of Science:

• Immunology
• Oncology
• Pediatrics

Background:

• Combined immunodeficiency (CID) due to CD70 deficiency presents with infections, hypogammaglobulinemia, and increased malignancy risk.
• Patients often exhibit chronic Epstein-Barr virus (EBV) viremia, hemophagocytic lymphohistiocytosis, and lymphomas.
• Plasmablastic lymphoma (PBL) is a rare aggressive lymphoma, typically associated with HIV infection in adult males.

Observation:

• This study reports the first pediatric case of PBL in a patient with CD70 deficiency.
• The patient presented with characteristics typical of CD70 deficiency and subsequently developed PBL.

Findings:

• The case establishes a novel association between CD70 deficiency and the development of PBL in a pediatric patient.
• This finding expands the known spectrum of malignancies associated with CD70 deficiency.

Implications:

• This case highlights the importance of considering rare malignancies like PBL in pediatric patients with primary immunodeficiencies, such as CD70 deficiency.
• Further research is warranted to understand the mechanisms linking CD70 deficiency and PBL development.
• Early recognition and management strategies may be crucial for improving outcomes in these rare cases.